Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Ishares Iv Plc - Ishares Msci Japan Esg Enhanced Ucits Etf Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €5.35 |
52 Week High | €5.44 |
52 Week Low | €4.85 |
Beta | 0 |
11 Month Change | 1.85% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 10.38% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
CEB3 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | -1.1% | 1.6% | 1.1% |
1Y | n/a | 41.5% | 18.9% |
Return vs Industry: Insufficient data to determine how CEB3 performed against the German Capital Markets industry.
Return vs Market: Insufficient data to determine how CEB3 performed against the German Market.
Price Volatility
CEB3 volatility | |
---|---|
CEB3 Average Weekly Movement | 3.1% |
Capital Markets Industry Average Movement | 4.8% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CEB3 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine CEB3's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | n/a |
Ishares Iv Plc - Ishares Msci Japan Esg Enhanced Ucits Etf Fundamentals Summary
CEB3 fundamental statistics | |
---|---|
Market cap | €1.19b |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs CEB3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CEB3 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did CEB3 perform over the long term?
See historical performance and comparison